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Abstract
Kunapuram, Deepa. Ph.D. The University of Memphis. December 2011. Solution
Conformation of Biologically Active Peptides as Determined by Hydrogen/Deuterium
Exchange and Mass Spectrometry. Major Professor: Dr.Chhabil Dass.
This research is focused on applying mass spectrometry based methods to
understand the conformational changes of bio-active peptides in solution. In this
dissertation, electrospray ionization mass spectrometry (ESI-MS) coupled with
hydrogen/deuterium exchange (HDX) has been employed to probe the secondary
structure of selected peptides in membrane-mimetic environments. The membranemimetic systems used in our study include water and trifluoroethanol (TFE). HDX of the
amide protons in native proteins depends on the solvent accessibility and spatial
arrangement of amino acid residues, thus providing information about the secondary
structure of a protein. A total of six biologically active peptides have been chosen for this
study. The dissertation consists of six chapters; the first two are introductory in nature,
and both of which discuss the background information about peptides, basic concepts
involved in ESI-MS, HDX, and MS instrumentation. The remaining three chapters
provide discussion on structural investigation of the peptides containing similar
sequences. Dynorphin A (1-8) and bovine adrenal medulla dodecapeptide 12P (BAM
12P) with a similar message domain (YGGF), are the two opioid-related peptides whose
structures have been investigated and discussed in Chapter 3. The solution structure of
these peptides was probed using mass spectrometry and circular dichroism (CD)
spectroscopy techniques. While CD data gave an idea about the type of probable
secondary structure; data obtained by tandem mass spectrometry helped in identifying the
elements involved in the secondary structure formation of the target peptides.
iv

In water, dynorphin shows open conformation whereas; BAM 12P exhibits ordered
structure to some extent which is further evident from the exchange numbers obtained
from HDX-MS experiments. Both dynorphin and BAM 12P assume a β-turn
conformation in TFE. Chapter 4 deals with the similarity in the conformational analysis
of the peptides bombesin (BBS) and neuromedin B (NMB). A common character of these
peptides is the C-terminal sequence G-H-X-M-NH2. Both BBS and NMB are known to
act on the G-protein coupled receptors with a varied physiological response. The HDXMS experiments revealed that both the peptides show dis-ordered conformation in water
and exhibit helical conformation in TFE. Chapter 5 discusses the conformational
structures of substance P (SP) and kassinin. These two peptides belong to the family of
tachykinins and share a common C-terminal sequence Phe-X-Gly-Leu-Met-NH2 and a
varied N-terminal sequence. The biological actions of these peptides are also mediated
through specific G-protein–coupled neurokinin receptors. The structural analysis of SP
and kassinin using HDX-MS in TFE revealed that; SP shows two β-turns followed by an
extended turn in the C-terminal, kassinin exhibits β-turn in the N-terminal followed by a
helical conformation in the remaining portion of the peptide. In water, both the peptides
assume random coil conformation. Lastly, chapter 6 summarizes the objectives obtianed
in the current research.
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Chapter 1
Introduction
The focus of the present dissertation is investigation of the conformations of bioactive peptides in solution-phase using mass spectrometry techniques. Chapters 1 and 2
of the thesis summarize the underlying concepts that are involved in the methodology
used to investigate the secondary structures of the target peptides; the results are
discussed in chapters 3, 4 and 5. These studies were carried out in water and mixed
water-trifluroethanol solvent systems using electrospray ionization mass spectrometry
coupled with hydrogen/deuterium exchange.
The study of structural determination of target peptides chosen for this thesis is
divided into three different projects based on their sequence similarity:
1. Solution-phase conformation of dynorphin A (1-8) and bovine adrenal medulla
dodecapeptide.
2. Structural investigation of bombesin and neuromedin B.
3. Conformational characterization of substance P and kassinin using mass spectrometry
Protein Chemistry
Proteins are large biopolymers formed by joining amino acids through peptide
bonds. They may contain one or more of such chains and may exist as random or folded
structures. Proteins are essential constituents of cells and play a dominant role in almost
all physiological processes of living systems.
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For example, all chemical reactions in the living systems are catalyzed by enzymes,
which are protein molecules. Also, proteins participate in various life processes such as
respiration, muscular contraction, active transport of cellular constituents, electrical
transmission, and in the expression of genetic characteristics [1, 2]. They also function as
hormonal regulators of metabolism, as storage depots for certain molecules, in
immunological defense mechanisms, and as structural elements of body tissues.
Proteins and peptides are composed of 15 to 25% nitrogen and about an equal
amount of oxygen. The distinction between proteins and peptides is their size. Some
proteins exist as the combination of subunits of polypeptide molecules. Peptides can be
categorized as smaller proteins; having molecular weights less than 10,000 Da, formed by
linking of α-amino acids in a defined order [1, 2]. The link between two amino acids is
formed by joining of α-carboxyl group of one amino acid and α-amino group of the next
amino acid. This link is known as an amide bond or a peptide bond. The repeating
structure of amino acids linked to one another by peptide bonds is referred to as the
backbone of a polypeptide chain. The peptide bond is planar in nature owing to
delocalization of the electrons from the carbonyl double bond. The planar nature of the
peptide bond imposes constraints on the number of possible orientations that may occur
when two or more amino acids are joined in a polypeptide chain. These orientations
(Figure 1) are described by the angles of rotation φ at the Cα-N bond and ψ at the Cα-C
bond. These rotations occur to minimize steric hindrance and maximize the stability
between the neighboring groups.
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Another important stabilizing element in the polypeptide structure is the ability to form
hydrogen bonds. Although a hydrogen bond is considered as a weak interaction, it acts as
an important stabilizing factor in a polypeptide chain.
Structure of Proteins and Peptides
Proteins are commonly characterized by four levels of structure: primary,
secondary, tertiary and quaternary. In primary, secondary and tertiary structures, all
amino acids are arranged in a single polypeptide chain, whereas the quaternary structure
refers to the interaction of two or more polypeptide chains to form a multi-chained
protein.
Primary structure. The primary structure refers to the number of amino acids
arranged in a specific sequence (Figure 2). The covalent peptide bond is the only type of
bonding involved at this level of the protein structure. Investigation of the primary
structure is a first step in the characterization of a protein. Proteins with different
activities have widely different primary structures, whereas those having similar roles
have similar sequences. For example, hemoglobin from different species of animals
differs in primary structure by a few amino acids, yet they have same function.
Since 1960, extensive research has been done to determine the primary structure
for a large number of proteins; notably among these accomplishments are sequencing of
a) enzymes; e.g., cytochrome c (104 residues), chrymotrypsin (246 residues), b) viruses;
e.g., tobacco mosaic virus protein (158 residues), c) biologically active protein
molecules; e.g., myoglobin (153 amino acids), human haemoglobin (two chains, 141 and
146 amino acids respectively), and others [4].
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Figure 1. Linking of amino acids in a polypeptide chain.
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Figure 2. Representation of the primary structure of protein.
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Secondary structure. The existence of secondary structure in proteins (Figure 3)
was postulated by Pauling et al. [2]; It is defined as a regular pattern of the backbone of
polypeptide chain into α-helix, β-sheet and turns. The most commonly seen secondary
structure in proteins is α-helix, which is stabilized by intra-chain hydrogen bonding. The
β-sheets are formed due to hydrogen bonding between two or more parallel or antiparallel strands. Turns are the type of secondary structures that give polypeptide chain the
flexibility to bend and thus reorient itself to produce the required compact and globular
structure. The most common type observed in many proteins is β-turn, in which the
carboxyl group of one amino acid residue is hydrogen-bonded to the amide proton of the
amino acid residue at three positions down the chain to form a tight loop.
Tertiary and quaternary structures. The arrangement and inter-relationship of
the twisted chains of a protein into specific loops is called the tertiary structure of a
protein. Tertiary structure (Figure 4a) is described by how the chains with secondary
structure further interact through the R groups of the amino acid residues to give an
energetically most favored three-dimensional (3D) shape. Tertiary structure is stabilized
by four types of interactions such as, hydrogen bonds, salt bridges, non-polar
hydrophobic interactions and disulphide bonds.
The fourth level of structural organization in proteins refers to the quaternary
structure (Figure 4b) in which the subunits of proteins are combined together in a defined
manner by non-covalent interactions. The forces that stabilize these structures are
hydrogen bonds, disulfide bonds and salt bridges formed between amino acids on the
polypeptide chains.
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A quaternary structure is composed of several subunits or monomers such as dimers and
tetramers; formed by the association of two and four subunits, respectively. A wellknown example of a quaternary structure of protein is hemoglobin consisting of four
peptide chains of α- and β- types that occur in pairs.

(a)

(b)

(c)

Figure 3. Different secondary structures of a protein: (a) α-helix, (b) β-sheet and (c) βturn.

(b)

(a)

Figure 4. Depiction of (a) tertiary structure and (b) quaternary structure.
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Conformation of Proteins and Peptides
The knowledge of higher-order structures of peptides and proteins is important in
understanding their biological functions. The changes that occur in conformation can be
used to monitor protein’s function. Several approaches have been made to predict the
conformations of proteins bound to their biological receptors [5-7].
In general, a peptide hormone first interacts with membranes surrounding the
receptor to form a nascent secondary structure before it binds to the receptor. Therefore,
in vitro conformational analysis of proteins and peptides is usually carried out in
secondary structure-inducing media such as membrane-mimetic environments consisting
of organic solvents (2,2,2-trifluoroethanol (TFE), methanol, and isopropanol), lipid
vesicles, detergents, etc. These studies enable us to understand the secondary structure of
the peptides responsible for their biological activity [5-7]. The secondary structure of
peptides is known to be largely influenced by the external environment that surrounds the
peptide. For example, a peptide segment that exists as a -turn in a protein, may exhibit a
helical conformation in the presence of an external solvent. In solution, most peptides
assume multiple flexible conformations. Conformational studies will not only help in
identifying the initiation sites involved in the folding process of a given protein, but will
also shed light on the roles of the side chains in dictating the secondary and tertiary
interactions. In this research, TFE is used as a solvent system that simulates the
membrane environment.
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Several properties of TFE such as hydrogen-bonding and hydrophobic properties
are known to facilitate the secondary structure formation in peptides. The dielectric
constant of TFE is approximately one-third that of water, a property that helps to
strengthen the intramolecular interactions in peptides. Also, TFE is a weaker base than
water and thus forms weaker hydrogen bonds with the carboxyl and the amide groups of
peptides. Thus, TFE promotes the internal hydrogen bonds of the peptide. Furthermore,
TFE has the capability to form a hydrophobic core by generating clusters in the aqueous
solution. Hence, by aggregating around the solute, TFE molecules exclude water to
promote intramolecular hydrogen bonding [8-10]. As a result of all these factors, TFE is
known as a secondary structure-inducing solvent.
Techniques for determining conformational changes. Several methods are
available to determine the conformational states of peptides and proteins. These include
nuclear magnetic resonance (NMR), circular dichroism (CD), X-ray crystallography,
infrared spectroscopy (IR), Raman spectroscopy, fluorescence spectroscopy, ultraviolet
(UV)-visible absorption and mass spectrometry (MS) [12-17]. NMR and X-ray
crystallography provide the detailed information about the conformation of polypeptides.
X-ray crystallography gives information regarding the atomic distance of a compound,
but is limited to only those proteins that can be crystallized readily. NMR spectroscopy
provides the information about tertiary structural elements of proteins in solution. One of
the major limitations of these two techniques is that they require large amounts of
samples. Depending on the magnetic field used, the accessible mass in NMR
spectroscopy is limited to proteins with low molecular weights (< 30,000 Da.), and
requires lower pH and greater analysis time than MS [16].
8

Circular dichroism is also an established technique in the characterization of the
secondary structure of proteins. CD spectroscopy uses the "far-UV" spectral region (190250 nm) to provide information on the secondary structure of proteins. At these
wavelengths the peptide bond acts as a chromophore. The CD spectra displays
characteristic absorption bands based on the type of secondary structure present: α-helix
protein shows two negative bands of similar magnitude at 222 and 208 nm, and a positive
band approximately at 190 nm. The spectrum for a β-sheet protein has in general a
negative band between 210-220 nm and a positive band between 195 - 200 nm. The
spectrum for a disordered (random) protein shows a negative band approximately about
195 nm and a positive one at 212 nm. While CD spectroscopy gives information about
the type of secondary structures of the peptide; mass spectrometry provides an insight
into the elements of the peptide involved in secondary structure formation. Mass
spectrometry has emerged as one of the most exciting techniques for the study of protein
folding [26,27,44]. It provides high detection sensitivity and molecular specificity
[13,18]. Recent developments in soft ionization techniques: electrospray ionization (ESI)
by Fenn et al. [19] and matrix-assisted laser desorption/ionization (MALDI) by the
research groups of Hillenkamp et al. and Tanaka et al. [20] have added to a greater
improvement in protein chemistry. These techniques enable large and nonvolatile
molecules like proteins and peptides to be generated as intact gas-phase ions without
causing major damage to the biomolecule. In addition, these techniques improved the
detection sensitivity further to the attomole and zeptomole range [21].
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For the purpose of characterization of conformational modifications in proteins
and peptides, folding-unfolding dynamics of proteins and non-covalent complexes of
biomolecules; mass spectrometry is combined with two techniques, namely charge-state
distribution (CSD) and hydrogen/deuterium exchange (HDX). The charge-state
distribution in the ESI mass spectrum is simplest among the two techniques. The basis of
CSD to estimate the conformation is that the basic residues (Lys, Arg, His) can attach
protons to produce multiple charge states [M+nH]n in ESI. In its native folded structure,
the basic sites in a protein may be protected from the solvent, making them inaccessible
to protonation. When the structure is unfolded by the factors like temperature changes,
addition of organic solvents and detergent, a distinct profile of the charge-state
distribution is obtained; the CSD shifts to lower m/z range due to the attachment of
protons to the more available basic sites. Although CSD is easy to perform, it has
disadvantages in that it is easily affected by the instrumental variations such as gas flow,
temperature and voltage, and is less usable for peptides that have fewer basic sites [2226].
Hydrogen/Deuterium Exchange (HDX)
HDX has established itself as a standard protocol for monitoring conformational
changes in proteins and peptides [32-35]. In this research, HDX coupled with mass
spectrometry was employed to investigate the solution-phase conformation of the target
peptides. HDX can be studied using various instrumental techniques, such as NMR, CD,
FT-IR and MS; of which, NMR and MS are more popular for the conformational analysis
of proteins and peptides.
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NMR is capable of determining exchange rates at individual amide linkages with high
resolution and can produce site-specific information, but requires larger samples and
greater analysis time as compared to mass spectrometry. Katta and Chait were the first to
demonstrate the coupling of HDX labeling with MS [22]. The combination of HDX with
MS is emerging as a preferred method to investigate the higher-order conformation of
proteins and petides. [36-40]. MS not only requires smaller samples and lesser analysis
time, it also has the advantages of high sensitivity, speed and ability to analyze larger
protein molecules [12,19-20]. Matrix-assisted laser desorption/ionization mass
spectrometry (MALDI-MS) is another important technique that serves as a method for
monitoring HDX in the investigation of the solution-phase conformation of biomolecules [28,29]. MALDI has the advantages of better resolution and faster analysis
time, and does not require HPLC separation of the proteolytic fragments prior to mass
analysis [30,31].
HDX of a native protein depends on the solvent accessibility and spatial
arrangement of the hydrogen atoms. Therefore, only those hydrogens that are not
involved in intramolecular hydrogen bonding exchange with deuterium atoms. For every
hydrogen atom exchanged with deuterium, there is a mass change of one amu; Thus the
overall increase in the mass is a direct measure of the number of hydrogens exchanged in
that particular protein or peptide.
The mechanism of HDX can be conveniently understood by considering the
backbone of polypeptide chain, which consists of three different types (Figure 5) of
hydrogens [13,17]. The hydrogens covalently bonded to carbon, essentially do not
undergo any exchange.
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The second category hydrogens are at the side chains that exchange very fast and thus are
difficult to detect. In contrast, the amide hydrogens exchange with half-lives that vary
from milliseconds to years and can be conveniently measured experimentally. Therefore,
hydrogen exchange rates can be measured along the entire length of the protein using
backbone hydrogens.

Amide backbone H’s
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Figure 5. Polypeptide chain.
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Amide hydrogen exchange in proteins. The exchange rate of amide hydrogens
is dependent on the conformational states of peptides; the faster exchange indicates a
more open structure, and the slower exchange refers to a tightly folded state. In the native
form, the hydrogens that are on the surface, exchange at a faster rate compared to those
that are buried in the inner-core of a protein. Other factors that influence the exchange
rate are pH, temperature, inductive and steric effects of adjacent amino acid residues.
Hydrogen exchange in proteins is catalyzed by both H+ and OH- ions. At higher pH
values, the exchange rate is affected by OH- ion activity, and at lower pH, it is affected by
the H+ ion activity.
The rate constant for HDX, kex is given as the sum of the rate constants for acidcatalyzed (kH) and base-catalyzed (kOH) reactions; mathematically represented by
equation below [13]:
k ex  k H [ H  ]  k OH [OH  ]

The folding dynamics in proteins can be correlated to two rate-limiting processes
shown by Equations 1 and 2:
f
F ( H ) 
F ( D)

k

K2

K1

( )

( )

K1

( )

K-1

(1)

( )

(2)

K-1

These equations represent the fluctuations of the folded state and global unfolding
respectively. The terms F and U denote the folded and unfolded forms of a protein, H and
D refers to the hydrogen and deuterium.
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Eq. 1 is useful for determining the isotopic exchange directly from the folded form of
protein, whose rate constant is given as kf. It illustrates the isotopic exchange of only
those hydrogens that are accessible to the deuterated solvent; β is the probability that the
amide hydorgens make contact with the deuterated solvent. Eq. 3 describes the exchange
rate constant kf, in which the value of β will be equal to 1 when all the amide hydrogens
of a completely unfolded protein are exposed to the solvent. Eq. 2 gives the reversible
folding and unfolding dynamics of a protein. The terms k1 and k-1 are the rates of the
protein unfolding and refolding processes, respectively and k2 refers to the exchange rate
of amide hydrogens for the completely unfolded protein. The rate constant for the overall
process kex,, is given by Eq. 4.

k f    k2

k ex 

k1  k 2
k 1  k 2

(3)

(4)

The exchange mechanisms are categorized as EX1 and EX2 types [13]. The EX2
mechanism is a process in which the interconversion between folded and unfolded
structures of a protein is much faster than the isotopic exchange and k2 << k-1. The
opening and folding of a protein will occur many times before any isotopic exchange
takes place and therefore the overall rate constant is given as kex = k2(k1/ k-1) = K k2. If
the inter-conversion between the open and closed structures is slow, it is represented by
EX1 mechanism. In this process, k2>> k-1 and the rate limiting step is given by k-1, where
the exchange is directly related to the unfolding rate constant k1 (i.e kex = k1). Therefore,
by knowing kex and k2 values from the overall rate constant for EX2 mechanism, it is
possible to estimate the magnitude of the folding-unfolding equilibrium constant, K [41].
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To study the HDX of a protein using electrospray ionization mass spectrometry
(ESIMS), the protein is labeled with D2O and after a desired time interval, the exchange
is quenched at pH 2.5 and 0ºC. It is then digested with pepsin to yield small fragments
which are analyzed by ESIMS. The variation of HDX rate as a function of pH for
polyalanine is shown in the Figure 6. From the figure, it is clear that the rate of HDX is
minimal at pH 2.5. Thus, by applying these parameters, it is possible to measure HDX at
specified time intervals.

Rate constant

pH

Figure 6. Plot of the rate constant for isotopic exchange of hydrogens located in the
peptide amide linkages in polyalanine as a function of pH. The rate of deuterium
exchange is found to be the lowest at pH 2.5 [41].
15

Chapter 2
Introduction to Mass Spectrometry Techniques
Mass spectrometry is a technique that enables one to measure the individual
masses of molecules and atoms. The operation of mass spectrometry can be described in
three simple steps. The first and the foremost is the conversion of analyte molecules into
gas-phase ions. The excess energy transferred to the molecules result in fragmentation. In
the next step, the ions enter a mass analyzer where they are separated on the basis of m/z
ratios; finally, the ion current due to these mass-separated ions is detected and displayed
in the form of a mass spectrum.
The essential components (Figure 7) of a mass spectrometer include; an inlet
system which enables the transfer of the sample into the ion source, a vacuum system to
maintain low pressure, an ion source to convert the neutral sample into gas-phase ions, a
mass analyzer to separate the ions based on their mass-to-charge ratios, a detector to
measure and amplify the ion current due to mass-separated ions, electronics to control the
operation of all the units and finally a data system to record, store, and display the data.
Some advantages of mass spectrometry over other techniques include unsurpassed
molecular specificity, high detection sensitivity, high resolution and applicability to a
wide variety of samples (volatile, non-volatile, polar, non-polar, solid, liquid, and
gaseous materials).
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Figure 7. A schematic representation of the essential components of a mass spectrometer.
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Mass Spectrometry Systems
Electrospray Ionization Mass Spectrometry (ESI-MS)
ESI is a soft ionization technique, applicable to a wide range of compounds that
are present in the solution phase [13,40,41]. In ESI, the solvent flows continuously at the
rate of 2‐5 µL/min through a stainless steel capillary tube into the ion source (Figure 8a).
The solvent consists of a 1:1 (v:v) mixture of water and an organic solvent (e.g.,
acetonitrile, methanol, isopropanol), and a small amount of an acid (e.g., acetic acid).
The sample is injected into the solvent stream. A potential difference of 3-4 kV between
the capillary and a counter electrode in the source produces the electrostatic field that
disperses the emerging solution into a mist of fine droplets. A flow of dry gas such as
nitrogen and heat are used to evaporate the solvent and reduce droplets in size until
highly charged ions are desorbed intact without undergoing fragmentation. The resulting
charged ions are sampled through an orifice into an intermediate vacuum region (Figure
8b), and eventually through a small aperture into the mass analyzer, which is held under
high vacuum. Several parameters such as the flow rate, temperature of the ion source,
conductivity, and surface tension of the solvent must be controlled to obtain a stable
spray of the emerging sample. In the electrospray process, the ions observed are
quasimolecular ions formed by the addition of a proton, e.g., [M + H]+ or of another
cation such as sodium ion, [M + Na] +, or the removal of a proton, [M - H]-. The
multiply-charged ions, of the type [M + nH]n+ or [M - nH]n- are also observed for larger
molecules.
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The electrospray technique offers certain variations and the most important ones
are microspray and nanospray. A primary difference between these two is the reduced
flow rate of the analyte solution, µL/min and nL/min (<0.5 µL/min) respectively. An
important advantage offered by nanospray is its increased performance owing to the
lowering of the inner diameter of the spray needle and usage of reduced potentials as
compared to those used in ESI.
Mechanism of ion formation in ESI. Two mechanisms are proposed to explain
the processes of ion formation. According to one mechanism, called the charge residue
model (CRM), the droplet loses solvent molecules, increasing the charge density on its
surface until the repulsive columbic forces overcome the droplets surface tension. At this
point, a bigger droplet breaks into smaller ones. This evaporation-fission cycle continues
until the droplet contains just one solute molecule when the final traces of the solvent are
evaporated, and the entire charge is retained by the solute molecule to produce individual
ions. Another proposed mechanism is an ion desorption mechanism (IDM), in which the
droplets do not reduce to a size containing only one analyte molecule; but shrink by
evaporation of the solvent until the electric field due to the surface charge density
overcomes the cohesive force leading to direct desorption of ions.
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Figure 8. A schematic representation of (a) a generic ESI technique; (b) a specific ESI
source showing sampling of ions through an orifice.
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Quadrupole Mass Analyzer
A quadrupole mass analyser consists of four parallel rods that have fixed dc and
alternating rf potentials applied to them. The two opposite rods in the quadrupole have a
positive potential of “+(U+Vcos(ωt))” and the other two have a negative potential of “(U+Vcos(ωt))”; where U is the fixed dc potential and Vcos(ωt) is the applied rf potential
of amplitude 'V' and frequency 'ω'. The applied potentials on the opposing pairs of rods
vary sinusoidally as cos(ωt) cycles with time 't'. This enables the ions to travel in the field
free region along the central axis of the rods along with oscillations amongst themselves.
These oscillations result in complex ion trajectories dependent on the m/z of the ions.
Specific combinations of the parameters 'U' and 'V' and 'ω' will result in specific ions
having a stable trajectory through the quadrupole to the detector; all other m/z values will
have unstable trajectories. Thus, the ion motion depends on the electric fields causing
only ions of a particular m/z to attain stable trajectory and thus pass through to the
detector. The rf and dc voltages are varied keeping the ratio rf/dc constant such that the
ions of different m/z are focused onto the detector to generate a mass spectrum. The ions
with unstable trajectories hit the quadrupoles and are lost.
Ion-Trap Mass Analyzer
An ion-trap mass analyzer is a three-dimensional analog of a quadrupole mass
analyzer; it consists of three electrodes; a doughnut shape central electrode and two endcap electrodes each with hyperbolic cross-section. A pictorial representation of the ITMS
is shown in Figure 9a. One of the end-cap electrodes has a small opening through which
enters a gated beam of electrons for the sample ionization and the other end-cap electrode
has several perforations through which the ions exit the trap for detection [43].
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To create a three-dimensional quadrupole field; the ring electrode is held at a
potential of Ф0 = U – V cos ωt and the end cap electrodes are held at zero potential. The
terms “U” and “V” are the amplitudes of dc and rf potentials and “ω” refers to the
angular frequency. The field traps the ions in a stable oscillating trajectory. The exact
motion of an ion is dependent on the voltages applied, their individual mass-to-charge
(m/z) ratios and the size of the ion trap (r). The dependence of ion motion on these
parameters is given by the dimensionless parameter qz and the effect on the motion of
ions when a dc potential is applied is given by a similar parameter az. Most of the
commercially available ion trap analyzers work in rf-only mode, where az = 0. The terms
qz and az are given by the Eq. 5

qz =

4eV
m / zr 2 2

(5)

From Equation 1.5, it is obvious that m/z α V/qz. It is also understood that larger values of
m/z will have smaller qz values and vice-versa. It is possible that the ions of different m/z
values may have stable orbits at the same time. A stability diagram (Figure 9b) has been
plotted which shows a theoretical region where radial and axial stability overlaps.
Depending on the amplitude of voltage applied to the central electrode, only those ions
will be trapped whose m/z will have qz and az values falling within the boundaries of the
stability diagram and all other ions are lost whose qz and az values falls outside the
boundaries of the stability diagram.
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There are different modes of operation for IT mass analyzers; two of them, massselective instability mode and resonance ion ejection mode are discussed here. The ions
oscillate in the trap with a frequency known as the secular frequency, determined by the
values for qz, az and the frequency of the fundamental rf. In the rf-only mode or the massselective instability mode, the end cap electrodes are held at ground potential and only
the ring electode is subjected to the rf voltage. As a result, a purely oscillatory field is
generated which causes the locus of all the trap ions to fall on the qz axis. Thus, the trap
behaves as an ion storage device. At a given value of V, all ions for which the qz lies
between 0 and 0.908 are trapped within the quadrupole field. To obtain a mass spectrum;
the fragment ions are sequentially ejected in the ascending order of their m/z values
which is made possible by increasing the voltage V and thereby decreasing the qz value of
the ion. This phenomenon results in the ejection of ions through holes in the end-cap
electrode along the z direction and are analyzed using electron multiplier detector.
Another mode of operation of an ion trap mass analyzer is the resonance ion
ejection mode. In this mode, an auxiliary rf signal of relatively small voltage is applied to
the end-cap electrodes in such a way that the qz value of the ion changes until it reaches a
point where the secular frequency of the ion matches the frequency of the applied
voltage. At this point, the ions of resonant signal absorb energy and are thus excited to
the higher orbits where they are ejected from the trap. Therefore, it is possible to
accumulate the ions of interest, while the remaining ions are selectively removed.

23

This mode is useful because it allows ejection to occur at voltages lower than those
required for ejection required at qz = 0.908. Some advantages of ion trap mass analyzers
include; simple operation, less expensive and high scan speed. Also, their small size and
low pumping requirements makes them widely acceptable for field applications.
Linear Ion-Trap Mass Analyzer (LIT)
A linear ion trap is similar in construction to quadrupole mass analyzer except
that; it uses a set of quadrupole rods and static electrical potential on-end electrodes to
confine ions radially and axially, respectively [17]. LIT is also designed with four parallel
rods and uses rf and dc potentials for mass separation and analysis. LIT is also called a
two-dimensional quadrupole ion trap because, it consists of two pairs of hyperbolic rods
with each pair fractioned into three axial sections (one at the center and two at the end).
Along the length of one of the rods of the central section, there is a small slit that enables
the ejection of ions for detection. The ions are trapped either axially by applying three
separate dc potential to the three sections of the trap or, radially by the application of rf
potentials between the opposite electrode pairs. For mass analysis, mass-selective
instability mode is used in which the main rf voltage is increased at a constant rate such
that the ions of ascending mass become successively unstable radially and are ejected
through the exit rods. In addition to all other advantages of IT mass analyzers, LIT offers
increased ion storage capacity and faster scans times.
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Figure 9. Pictorial representation of (a) ion-trap mass analyzer and (b) stability diagram
in the quadrupole ion trap parametersized in terms of the operating voltages and
frequencies.
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Instrumentation
ESI is usually interfaced with a quadrupole or an ion trap mass spectrometer
(ITMS) and the combination has proved to be a powerful tool to characterize peptides
and proteins [42]. However, direct interfacing of ESI with an ion trap has certain
limitations: ESI works at atmospheric pressure and IT operates under reduced pressure,
therefore a suitable interface is required. Furthermore, ESI generates a continuous stream
of ions while the IT works in the pulse mode. This issue can be resolved using a linear
RF-only multipole assembly between these two devices such that the ions are first stored
in the RF region for a short time and then introduced into the IT in the pulse mode. An
ITMS is a compact, cost-effective, highly sensitive and high-scan speed analyzer. It can
be conveniently connected with HPLC using an ESI interface (LC-MS). LC-MS provides
the combined advantages of both physical separation and mass analysis of proteins. ESI
has thus gained wide popularity because of the ease with which it can be interfaced with
chromatographic separation techniques. Apart from LC-MS, off-line ESI in the
nanospray mode is also used in protein mass spectrometry. It is a technique in which
proteins are digested on an electrophoresis gel to obtain small peptide fragments. The
resulting fragments are then desalted and transferred to an ESI capillary for analysis.
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Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI
TOF)

MALDI is another commonly used soft-ionization technique in biological
research [13]. In this technique (Figure 10), the sample is crystallized along with a
suitable matrix material; the selection of the matrix is based on the energy absorbing
properties at the wavelength of laser radiation.
The sample is irradiated with a laser beam of short pulses and high irradiance power. It is
believed that the analyte molecules are ionized by the transfer of a proton from the
matrix. The most common matrices used for proteins and peptides are sinapinic acid (3,5dimethoxy-4-hydroxycinnamic acid), 2,5-dihydroxybenzoic acid (DHB), cinnamic acid,
and -cyano-4-hydroxycinnamic acid (CHCA). Sinapinic acid is usually used for larger
polypeptides and CHCA is used for peptides. The mechanism of ion formation by laser
irradiation is believed to consist of at least three different pathways; photo-ionization,
acid-base reaction, and cluster decay of small particles. The ions seen in most MALDI
spectra are protonated molecules of the type [M+H]+ but, it is also possible to detect
doubly and triply charged ions with higher molecular weight analyte. MALDI has gained
popularity due to certain features such as analysis of multi-component biological samples
and cellular material without extensive purification, ability to measure the molecular
weight of proteins greater than 100 kDa with high accuracy. Also, the mass spectra
obtained are simple to interpret due to singly charged ions. Furthermore, this technique is
somewhat tolerant to contaminants like salts, buffers, lipids, and other species that are
usually present in biological samples [45-47].
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Time-of-flight mass analyzer. A TOF mass analyzer operates in a pulsescanning mode and this property makes it highly desirable to be coupled with a MALDI
source [48]. In the TOF mass analyzer, ions are separated on the basis of their different
velocities. The laser pulse and ion acceleration pulse are applied simultaneously. Ionized
species starting from the same position at the same time are accelerated by a constant
homogeneous electrostatic field. Thus, ions travel at constant kinetic energy that is equal
to zV, where z is the charge on ions and V the accelerating potential.
The kinetic energy and velocity of ions are given by equations 6 and 7. The
mass-to-charge ratios can be determined by measuring the time taken by the ions to travel
from the extraction region to the detector, as given in equation 8.

KE  zV  1 / 2m 2

(6)

  (2 zV / m)1 / 2

(7)

t  L /  L(m / 2 zV )1 / 2

(8)

The limitation of the TOF-MS is that its resolution is limited by the initial spatial
and velocity distributions of ions. Therefore, the performance of MALDI-TOFMS is
improved by two techniques: i) by operating the mass analyzer in the time-delayed
extraction (DE) mode and ii) by incorporating a reflectron ion mirror.
DE helps to improve velocity distribution. In this mode, the ions are stored for
some time in a field-free region within the ion source, and are then ejected by applying a
delayed extraction pulse. During the time delay, the ions rearrange their position in the
source according to their initial velocity, so that the ions with higher velocity gain less
energy from the extraction field and those with low velocity gain more energy.
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Thus, DE effectively improves the mass accuracy and resolution as a result of the
focusing of energy.
A reflectron is used to enhance mass resolution by improving spatial and energy
distribution. It is an electrostatic mirror that consists of a series of electrical lenses, each
with progressively increasing potential. In this technique, the fast-moving ions that reach
earlier at the mirror penetrate to a greater depth and stay there longer than slow-moving
ions. This extra time in the mirror compensates for shorter flight times of the faster ions
in the drift region with the result that all iso-mass ions arrive simultaneously at the
detector. This correction leads to an increased mass resolution for all stable ions in the
spectrum. The use of the reflectron and delayed extraction TOF is limited to the analysis
of peptides and small proteins because; for proteins beyond 10,000 Da, the peak
broadening due to metastable decay is usually greater than the broadening due to kinetic
energy distribution. An important advantage of this instrument is that it can be used in the
proteomic approach.
Tandem Mass Spectrometry
Tandem mass spectrometery (MS/MS) is a technique of combining two mass
spectrometers in time or space to obtain detailed structural information of the desired
molecule. Tandem mass spectrometry in space is obtained by coupling of two physically
distinct instruments. The three basic steps (Figure 11) involved in such a technique are
mass selection, fragmentation, and mass analysis. Ions with a certain mass are selected in
the first mass analyzer (MS-1); these ions are called precursor ions, which undergo
fragmentation in the intermediate region by collisions with a neutral gas atom resulting in
the formation of fragment ions, termed as product ions.
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This phenomenon is known as collision-induced dissociation (CID). In the third step,
these product ions are analyzed with the second mass analyzer (MS-2) to produce product
ions spectra. Thus, MS-1 separates a mixture of ions into individual ions, and MS-2
analyzes the product ions produced from each individual precursor ion [13]. Examples of
this type of instruments include; i) QqQ configuration instrument with three quadrupoles
where; Q refers to quadrupole mass analyzer, q (in lower case) is the reaction region and
ii) QTOF (quadrupole mass analyzer and time-of-flight mass analyzer). Unlike spacial
separation method which uses successive analyzers, separation through tandem mass
spectrometry in time is accomplished by trapping the ions in the same place (an ion
storage device), with multiple separation steps taking place over time. A quarupole ion
trap can be used for such analysis.
Tandem mass spectrometry with ion trap mass analyzer. To acquire an
MS/MS spectrum in an ion trap, desired single ion species known as precursor ions is
selected by ejecting the ions of a larger m/z ratio with the resonance ejection mode. In
this mode, the trapped ions oscillate within the boundaries of the trap. To accumulate the
desired ions within the trap, the RF voltage is ramped up such that, the ions with the same
frequency as an RF voltage sequentially absorb the energy from the resonant signal and
are promoted to the higher orbits until they are ejected from the trap.Further, an
excitation pulse is applied to the mass selected precursor ion to facilitate its collisions
with an inert bath gas (helium or argon), resulting in the formation of collision-induced
dissociation (CID) products. The ions that become sequentially unstable exit the trap, and
are detected by the detector.
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Figure 10. A pictorial representation of the MALDI TOF.
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Figure 11. A schematic representation of the sequence of steps in tandem mass
spectrometry (in time).
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Peptide fragmentation using tandem mass spectrometry. Peptides
fragmentation is reasonably well-understood through tandem mass spectrometry [13].
The fragmentation (Figure 12a) proceeds along the entire peptide backbone and
sometimes also shows some side-chain fragmentation with certain instruments depending
on the type of analyzer used. A magnetic sector/magnetic sector instrument will give rise
to high energy collisions resulting in many different types of side-chain cleavages;
quadrupole/quadrupole and quadrupole/time-of-flight mass spectrometers generate low
energy fragmentations with fewer types of side-chain fragmentations. There are three
different types of bonds that can fragment along the amino acid backbone: the NH-CH,
CH-CO, and CO-NH bonds. Each bond breakage gives rise to two species, one is neutral
and the other is charged, and only the charged species is monitored by a mass
spectrometer. The charge can stay on either of the two fragments depending on the
chemistry and relative proton affinity of the two species. Thus, there are six possible
fragment ions for each amino acid residue and these are labeled as a, b, and c ions having
the charge retained on the N-terminal fragments, and the x, y, and z ions having the
charge retained on the C-terminal fragments (Figure 12a) [11]. The most common
cleavage sites are at the CO-NH bonds which give rise to the b and/or the y ions. The
mass difference between two adjacent b ions or y ions is indicative of a particular amino
acid. The masses of the ions obtained by the fragmentation process following CID can be
used to interpret the amino acid sequence.
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It was observed that the [ M+2H ]2+ ions of peptides produce higher quality tandem mass
spectra as compared to those produced from [ M+ H]+ or [ M+3H ]3+ peptide ions but
limited to those peptides which do not contain histidine or proline in their sequence [44].
The sequence-specific secondary ions are also produced when the Arg-, Lys-,
Gln- containing primary ions undergo neutral loss of an NH3 molecule. Similarly, the
sequence-specific ions are produced when the loss of water molecule occurs from Ser-,
Thr-, Asp- and Glu- containing primary ions. The presence of immonium ions and
internal fragment ions (Figures 12b and c) formed due to the cleavage of two bonds in
the backbone are also evident in the CID spectra. The formation of internal ions is also
favored due to the presence of proline or aspartic acid residues in the polypeptide
sequence.
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Figure 12. Pictorial representation of (a) fragmentation pattern along the backbone of a

polypeptide chain, (b) Internal ion and (c) Immonium ion.
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Chapter 3
Solution-Phase Conformation of Dynorphin A (1-8) and Bovine Adrenal Medulla
Dodecapeptide
This chapter will throw light on the solution-phase conformation of the two opioid
peptides dynorphin A (1-8) and bovine adrenal medulla dodecapeptide (BAM 12P) in
aqueous and organic solvent systems. The task was accomplished using mass
spectrometry, coupled with HDX. Dynorphin (for brevity, dynorphin A (1-8) will be
written as simply dynorphin) is an octapeptide (8 amino acid residues) with the sequence
YGGFLRRI, and BAM 12P has 12 amino acids arranged in a sequence
YGGFMRRVGRPE.
Peptides Background
The opioid peptides and their G-protein-coupled receptors (delta, kappa, and mu)
are usually located in the central nervous system (CNS) and peripheral tissues. There are
three families of opioid peptides namely enkephalins, dynorphins, and endorphins. Each
class of opioid peptides is derived by enzymatic cleavage from a larger and independent
precursor; enkephalins from proenkephalin A, dynorphins from proenkephalin B
(prodynorphin), and endorphins from pro-opiomelanocortin. BAM 12P is a novel
dodecapetide known to be derived from the precursor-proenkephalin A [59].
In general, most opioid peptides elicit their physiological activity by binding to µopioid receptors, but dynorphins and BAM 12P are more selective towards κ-receptors
[60,61].
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Both dynorphin A (1-8) and BAM 12P contain a common message domain with the
sequence Tyr–Gly–Gly–Phe (YGGF) [57,58]. Dynorphins play a role in a wide variety of
physiological functions such as, pain regulation, motor activity, cardiovascular
regulation, respiration, temperature regulation, hormone balance, and the response to
shock and stress. BAM 12P is a neuropeptide which acts mainly towards the functioning
of CNS. To a lesser degree, it also participates in the functioning of the digestive and
cardiovascular systems and in pain regulation.
Materials and Methods
Dynorphin A (1-8), BAM 12P, bombesin, neuromedin B, substance P and
kassinin were purchased from American Peptide Company (Sunnyvale, CA, USA).
Deuterated solvents (TFE-d3 99 atom % D; acetic acid-d1, 98 atom % D; and deuterium
oxide, 99.9 atom % D) were obtained from Aldrich (Milwaukee, WI, USA).
Hydrogen/deuterium exchange. Stock solutions of all the peptides were
prepared by dissolving them in water at a concentration of 300 μM. The HDX was
initiated by diluting 1 µL of the stock solution with 9 µL of pure D2O or in various
combinations of TFE-d3 and D2O to obtain the desired final concentration (0, 20, 50 and
80%). For time-resolved experiments, the isotope exchange was initiated by mixing the
stock solution with 10 fold excess of either D2O or 50% TFE-d3/D2O. The exchange was
quenched at specified time points by adding chilled 10% acetic acid-d1 to bring the pH to
about 2.5 and the temperature to 0º C.
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These solutions were then immediately introduced into an ESI ion source. Back-exchange
was minimized by infusing the ESI capillary with the respective working deuterated
solvents for about 30 min prior to the start of measurement and continuously flushing the
ESI source with dry N2 during the MS measurements. A control test was performed to
evaluate the back-exchange under the experimental conditions and it was found that the
back-exchange is less than 6% [23].
Mass spectrometry analysis. Mass spectrometry experiments for opioid peptides
were performed on a Thermo-Finnigan LCQDeca quadrupole ion trap mass spectrometer.
The samples were filled in a 25-µL Hamilton syringe and infused at a flow rate of 0.4
µL/min into the nanoESI source using a syringe pump. The ion source was maintained at
100º C and a spray voltage of 2.2 kV. Mass spectra were acquired in the m/z range of
200-1000 for dynorphin and 200-1600 for BAM, with the collision energy set to 35-40%.
For the remaining peptides, mass spectrometry experiments were performed on a
Thermo-Finnigan LTQDeca linear ion trap (LIT) mass spectrometer in which the samples
were infused into the ESI source at a flow rate of 1 µL/min using a 50-µL Hamilton
syringe. The other parameters used were same but, with a varied spray voltage of 5 kV.
MS/MS spectra were acquired in the m/z range of 200-1800 for BBS, 200-1300 for NMB
and; 200-1500 for both substance P and kassinin.
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Hydrogen/deuterium exchange calculations. The given equation 9 is used to
calculate the total number of hydrogens exchanged in a given peptide molecule (Hx) [53]:
Hx = [MD – M] = n [(m/z) D – D+] – M

(9)

where, M is the molecular mass of the non-deuterated peptide, MD is the
molecular mass of the partially deuterated peptide and (m/z)D is the mass-to-charge ratio
of the nth charge state of the partially deuterated peptide.
The percent incorporation of deuterium in each peptide molecule can be
calculated as:
D = Hx/Ht * 100%; Ht corresponds to the total number of exchangeable hydrogens.
Similarly, the number of hydrogens exchanged in b and y-type sequence-specific
ions can be calculated using the following equations [54]:
bj n+: Hx = n [MD (bj n+) – M (bj n+)]

(10)

yj n+: Hx = n [MD (yj n+) – M (yj n+)-1]-1

(11)

Circular dichroism experiments. The CD spectra for dynorphin and BAM 12P
in water (0.2 mg/mL; in 0.01 M Tris-HCl, pH 7.0) and 50% TFE/water were obtained on
AVIV 62DS circular dichroism spectropolarimeter. The data points were collected in
delta epsilon units between 190 nm and 260 nm at a wavelength step size of 1.0 nm and a
bandwidth of 1.0 nm.
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Results and Discussions I
Conformation of Dynorphin A (1-8)
Dynorphin A (1-8), with a sequence YGGFLRRI, contains a total of 19
exchangeable hydrogens: three on the N- and C- terminals, nine on the side chains and
seven on the peptide backbone. Figure 13 displays a zoom-scan ESI mass spectrum of
the [M+2H]2+ region of dynorphin in water (m/z 491.3). The zoom-scan spectra were also
obtained for HDX in 0, 20, 50 and 80% TFE-d3/D2O solvent mixtures. It was observed
that the m/z shifted from 491.3 to 500.4 (Figure 14) in D2O, indicating that an average of
16 out of 19 hydrogens have exchanged; the percent deuterium incorporation is
calculated to be 84.2%. In the 50% TFE-d3/D2O solvent mixture, the m/z shifted from
491.3 to 498.9 (Figure 16), indicating that only 13 (68.4%) hydrogens have exchanged
on an average. Similar interpretation of the data for 20 and 80% solvent mixtures
revealed that 14 (73.7%) and 12 (60%) hydrogens were exchanged, respectively. Thus, it
can be concluded that dynorphin assumes a more compact structure in higher
concentrations of TFE.
To understand the role of an organic solvent on enhancing the folding of the
peptide to a more compact form, time-resolved experiments were also performed using
water and 50% solvent mixture. A plot of the data obtained is shown in Figure 18. The
upper curve in this figure represents the HDX profile for dynorphin in D2O and the lower
curve is in 50% TFE-d3/D2O solution. In D2O, it was observed that almost all hydrogens
were exchanged within one min incubation time.
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In contrast, in TFE, the exchange was slow and the numbers of hydrogens exchanged
remained constant after the exchange period of 10 min. The deuterium incorporation in
both solvent systems did not change even after 24 h of exchange time interval. These two
distinct HDX profiles suggest that dynorphin exhibits different conformational states in
the two different solvent systems. It is obvious from the time-resolved plot that,
dynorphin shows a more disordered structure in aqueous media compared to that in TFE.
MS/MS Analysis for Dynorphin A (1-8)
To gain an insight into the specific amino acids of the peptide that are involved in
secondary structure formation, CID-MS/MS spectra were obtained for the peptide
samples in water and 50% TFE-d3/D2O solvent systems. It was observed that the Nterminal ions were abundantly present in the MS/MS spectra of the peptide in both the
solvent systems. The C-terminal ions were observed as y (y2, y3) ions or (y-NH3) (y4*, y6*
and y7*) ions. The loss of 17 Da (annotated by asterisk in the spectrum shown in Figures
19 and 20) refers to the loss of ammonia molecule from certain y-type primary ions.
This loss can be attributed to the presence of basic amino acid residues such as Arg6 and
Arg7 in the C-terminal segment. It was observed that nearly complete sequence coverage
was obtained considering the N-terminus ions; except b1/a1 (due to cut-off mass limit), all
other b/a ions were present (Table 1). Shorter segments of the target peptides rather than
individual amino acids were considered for determining the amino acids involved in the
secondary structure formation. The deuterium incorporation in such fragments was
calculated using equations 10 and 11.
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Interpretation of MS Data for Dynorphin A (1-8)
It is observed that for dynorphin, three out of 19 labile hydrogens in water and six
hydrogens in 50% TFE-d3/ D2O remained unexchanged. The examination of CIDMS/MS spectral analysis reveal that in pure D2O solvent, there was nearly complete
deuterium incorporation (98%-100%) in the N-terminal region, and significantly lesser
(<83%) in the C-terminal residues. Among the three hydrogens that remained
unexchanged in D2O, two belong to Arg6 residue and one belongs to the Arg7–Ile8
fragment.
Similarly, the numbers of hydrogens exchanged in the N-terminal and C-terminal
portions in 50% TFE-d3/D2O are shown in Table 2. The data obtained reveal that three
out of four and three out of five hydrogens were exchanged in the Tyr1-Gly2and Tyr1Gly3 segments respectively, indicating that two out of six unexchanged hydrogens belong
to the Tyr1-Gly3 segment. Similar analysis of hydrogens exchanged in the other Nterminal segments Tyr1-Phe4 (4/6), Tyr1-Leu5 (5/7), and Tyr1-Arg6 (8/12) show that two
more of the six protected hydrogens belong to Arg6 residue. These calculations were in
corroboration with the numbers obtained for the hydrogens exchanged in C-terminal
segments Arg7–Ile8 (5/7), Leu5-Ile8 (9/13), Gly3-Ile8 (10/15), and Gly2-Ile8 (10/16). From
these exchange numbers, it can be derived that the remaining two hydrogens that are
unexchanged belong to the Arg7–Ile8 portion. It is further concluded that the hydrogens in
the Phe4–Leu5 segment are not hidden from the solvent and are available for exchange.
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These conclusions have been made based on the numbers of hydrogens exchanged on Nterminal fragments; observations done on C-terminal ions cannot be completely relied on
due to scrambling effect [48-50]. The summary of numbers of hydrogens exchanged in
different segments of dynorphin is pictorially represented in Figure 21.
Circular Dichroism Analysis of Dynorphin A (1-8)
The CD plot for dynorphin obtained in water and 50% TFE/water is shown in
Figure 22. In TFE, dynorphin shows a minimum approximately at 222 nm and a positive
band (not a well-defined peak) in the 197 nm region indicating the presence of a β-turn
conformation. In water, the peptide shows the CD spectral characteristics of a
predominantly random-coil conformation with a negative band at about 196 nm and a
maximum at 215 nm. These results support the conclusions drawn from the HDX MS
data.
Secondary Structure Determination of Dynorphin A(1-8)
Although some research has been conducted on the conformation of the bigger
analog dynorphin A (1-13), no literature exists for dynorphin A (1-8) [64-66]. Dynorphin
A (1-13) attains α-helical structure in the N-terminal portion when in contact with the
receptor membranes and a ß-turn in dimethyl sulfoxide (DMSO) [67]. A recent NMR
study of dynorphin A (1-13) also indicates that a part of the molecule exhibits ß-turn
conformation in methanol, further concluding that the α-helical conformation is not an
essential requirement for the activity of dynorphin at κ-receptors [68]. In contrast, a
recent investigation by our research group on the conformation of dynorphin A (1-13)
indicated that it attains an α-helical conformation in TFE [70]. Therefore, it is also not
possible to completely rule out the existence of α-helical structure.
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A similar study from our group on the conformation of methionine and leucine
enkephalins (Tyr1–Gly2–Gly3–Phe4–Met5/Leu5); both of which have a sequence of first
four amino acids in common with dynorphin A (1-8), shows that both these peptides
display a ß-turn in TFE [69]. It is proposed that the amide proton of the Met5/Leu5 residue
interacts with the carbonyl group of Gly2 residue to form a ß-turn, and the OH proton of
Tyr1 interacts with the carbonyl group of Gly3 residue to form a hydrogen bond. Thus,
based on the data obtained from the existing experiments, it can be assumed that the one
hydrogen that remained protected in the Tyr1–Gly2 segment, correspond to Tyr1 residue.
Of the remaining unexchanged hydrogens, one belongs to Gly3 residue and four to the
Arg6-Ile8 segment. Therefore, based on the literature and current research, it can be
presumed that dynorphin A (1-8) adopts a ß-turn in TFE, with hydrogen bonding between
a carbonyl group of Gly3 and amide group of Arg6. The peptide assumes a random
structure in aqueous solvent. This conclusion is supported by the CD spectra obtained for
dynorphin A (1-8) in TFE, which demonstrated the characteristic peaks for ß-turn
conformation.
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` Figure 13. Zoom scan spectrum of dynorphin A (1-8) in water.
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Figure 14. Zoom scan spectrum of dynorphin A (1-8) in pure D2O.
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Figure 15. Zoom scan spectrum of dynorphin A (1-8) in 20%TFE-d3/D2O.
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Figure 16. Zoom scan spectrum of dynorphin A (1-8) in 50%TFE-d3/D2O.
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Figure 17. Zoom scan spectrum of dynorphin A (1-8) in 80%TFE-d3/D2O.
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Figure 18. Plot of the number of hydrogens exchanged in dynorphin A (1-8) as a function
of time in water and 50% TFE.
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[b7+H2O]+2

y7*
y6*
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a5
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Figure 19. CID-MS/MS Spectrum of dynorphin A (1-8) in water.
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[b7+H2O]+2

y7*

y6*
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Figure 20. CID-MS/MS Spectrum of dynorphin A (1-8) in 50% TFE-d3/D2O.
Note: The m/z peaks that are displayed in the spectrum and are left unlabelled
corresponds to the internal ions
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Table 1
A Amino Acid Sequence-Specific Ions Observed in the CID-MS/MS Spectrum of
Dynoorphin A (1-8) in Water and 50% TFE-d3/D2O Solvent Mixture
Ion type

m/z in water

a2
a4
a5
b3
b6
y2
y3
y4*
y6*
y7*

193.1
397.4
510.2
278.2
694.4
288.3
444.4
540.4
744.5
801.5

m/z in D2O

Hx in D2O

197.1
403.4
517.2
283.1
704.5
296.5
455.5
550.5
756.6
814.6

m/z in TFE

4
6
7
5
10
6
9
10
12
13

196.1
401.3
515.4
281.2
702.4
295.4
549.4
754.4
811.6

Hx in TFE
3
4
5
3
8
5
9
10
10

Table 2
Number of Hydrogens Exchanged in Various Regions of Dynorphin A (1-8) upon
HDX in 50% TFE-d3/D2O Solvent Mixture
N-terminal
segments

Number of hydrogens
exchanged

C-terminal
segments

(% Deuterium content)
YG
YGG
YGGF
YGGFL
YGGFLR

Number of hydrogens
exchanged
(% Deuterium content)

3/4 (75)
3/5 (60)
4/6 (67)
5/7 71)
8/12 (67)

RI
LRRI
GFLRRI
GGFLRRI

53

5/7 (71)
9/13 (69)
10/15 (67)
10/16 (63)

b2 3(4)

a4 4(6)

a5 5(7)

b6 8(12)

NH2-Y-G-G-F-L-R-R-I-COOH
y6 10(15)

y2 5(7)

y4 9(13)

y7 10(16)
4

2

Figure 21. Summary of the number of hydrogens exchanged on b and y fragments of
dynorphin derived from CID-MS/MS data in 50% TFE-d3/D2O. The total number of
labile hydrogens in each fragment is represented in parenthesis and the number of
unexchanged hydrogens in different segments is shown under the bar.
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Figure 22. Circular dichroism spectra of dynorphin A (1-8) in water and 50% TFE/water.
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Results and Discussions II
Bovine Adrenal Medulla Dodecapeptide Conformation
BAM 12P is a 12 amino acid long peptide (YGGFMRRVGRPE) that contains a
total of 27 labile hydrogens: three on the terminals, 10 on the amide backbone and 14 on
the side chains. The CID-MS/MS analysis was performed for HDX of BAM 12P in 0, 20,
50 and 80% TFE-d3/D2O. The zoom-scan ESI mass spectrum of the [M+3H]+3 region of
BAM in water is shown in Figure 23. The m/z shifted from 475.6 to 483.6 in 100% D2O
(Figure 24) that corresponds to the exchange of 21 hydrogens out of 27; the percent
deuterium incorporation was calculated to be 77.7%. In a 50% TFE-d3/D2O solvent
mixture, m/z shifted from 475.6 to 482.9 (Figure 26), corresponding to the exchange of
19 hydrogens (70.3%). Further, the HDX of BAM 12P in 20 and 80% solvent mixtures
revealed that 20 (74.1%) and 17 (63.3%) hydrogens were exchanged respectively. The
rate of exchange was slow and remained the same even after 24 h of time interval. A
similar conclusion is drawn from the time-resolved data for BAM 12P. Figure 28, which
is a plot of the number of hydrogens exchanged versus time shows that the exchange
profile for BAM in 50% TFE-d3/D2O (lower curve) is largely identical to that in the
aqueous solvent (upper curve). From these observations, it is evident that BAM exists in
nearly similar conformations in both the solvent systems.
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MS/MS Analysis for Bovine Adrenal Medulla Dodecapeptide
Since BAM 12P demonstrated very similar HDX profiles in both D2O and 50%
TFE-d3/D2O solvent systems, CID-MS/MS spectra were obtained for BAM 12P in water,
D2O and 50% TFE-d3/D2O solvent systems to identify the amino acids involved in the
folded conformation in both the deuterated solvents.
Similar to the fragmentation pattern of dynorphin (1-8), the CID-MS/MS spectra (Figures
29, 30, 31) of BAM contained more abundant N-terminal ions than C-terminal ions. The
loss of ammonia molecules was also observed owing to the presence of certain Argcontaining C-terminal y-type sequence-specific ions. The sequence-specific ions that
were used to calculate the deuterium incorporation are listed in Table 3.
Interpretation of MS Data for Bovine Adrenal Medulla Dodecapeptide
The interpretation of the MS/MS spectra of BAM 12P in D2O solvent shows that
all hydrogens were exchanged (100%) in Tyr1–Gly2 and Pro11–Glu12 segments and fewer
hydrogens exchanged in the middle region (Gly3-Arg10). A pictorial representation of
specific amino acids participating in the ordered conformation of the peptide is given in
Figure 32a.
It is observed that a total of eight labile hydrogens did not undergo exchange in
the 50% TFEd3/D2O solvent mixture. A detailed investigation of the MS/MS data (Table
4) obtained for BAM in the same solvent mixture shows that four out of six hydrogens in
the Tyr1-Phe4 segment; eight out of twelve hydrogens in Tyr1- Arg6 segment; and, 14 out
of 19 hydrogens in Tyr1-Gly9 segment were exchanged.
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Similar scrutiny of the sequence specific C-terminal ions reveals that the four hydrogens
in the Arg7-Glu12 portion and seven hydrogens in the Gly2-Glu12 region; remained
unexchanged. These observations indicate that although Tyr1–Phe4 segment is relatively
flexible, the region from Met5–Arg10 is more ordered. Further, it can be summarized that,
two hydrogens of Tyr1–Gly3, three hydrogens from Met5–Val8 and, three hydrogens from
Arg10–Glu12 are unexchanged (Figure 32b).
Circular Dichroism Analysis of Bovine Adrenal Medulla Dodecapetide
The CD spectra of BAM 12 P in water and 50%TFE/water is shown in Figure 33.
In water, BAM shows a negative CD band roughly at 197 nm and a small maximum at
around 214 nm indicating a disordered conformation. The CD spectral characteristics of
BAM in 50% TFE/water are similar to that of dynorphin with a negative band at about
218 nm and a maximum approximately in the 195 nm region indicating a ß-turn
conformation. These observations are in co-ordination with the conclusions drawn from
the HDX MS data.
Secondary Structure Analysis of Bovine Adrenal Medulla Dodecapeptide
The CD spectra of BAM indicate that it assumes predominantly a β-turn
conformation in TFE. From the MS/MS data of BAM in TFE, it is observed that two
hydrogens from Tyr1–Gly3, three hydrogens from Met5–Val8, three hydrogens from
Arg10–Glu12 are not free to undergo HDX. Based on these data and conformation of Metenkephalin (YGGFM), it is reasonable to assume that BAM adopts a ß-turn conformation
in the N-terminal segment, presumably involving a hydrogen bond between NH-Met5 and
CO-Gly2 residues [69].
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Previous researchers also proposed that the aromatic side chains of Tyr1 and Phe4 interact
with the κ-receptors to elicit the biological response and that they exist in relatively free
form prior to interaction with the receptor. Further, the residues Arg6–Arg7, Arg10, and
Glu12 are involved in solute-solvent interactions through hydrogen bonding.
Therefore, from the correlation of the present data with the literature, it is
reasonable to conclude that the two hydrogens that remained unexchanged in the Tyr1Phe4 segment correspond to Gly2 and Gly3; Tyr1 and Phe4 undergo exchange. The
fragments Arg6-7, Arg10, and Glu12 participate in hydrogen bonding with the solvent more
readily [71-73].
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Figure 23. Zoom scan spectrum of bovine adrenal medulla dodecapeptide in water.
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Figure 24. Zoom scan spectrum of bovine adrenal medulla dodecapeptide in pure D2O.

61

Figure 25. Zoom scan spectrum of bovine adrenal medulla dodecapeptide in 20% TFEd3/D2O.
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Figure 26. Zoom scan spectrum of bovine adrenal medulla dodecapeptide in 50% TFEd3/D2O.
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Figure 27. Zoom scan spectrum of bovine adrenal medulla dodecapeptide in 80% TFEd3/D2O.
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Figure 28. Plot of the number of hydrogens exchanged in bovine adrenal medulla
dodecapeptide as a function of time in water and 50% TFE.
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Figure 29. CID-MS/MS Spectrum of bovine adrenal medulla dodecapeptide in water.
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Figure 30. CID-MS/MS Spectrum of bovine adrenal medulla dodecapeptide in pure D2O.
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Figure 31. CID-MS/MS Spectrum of bovine adrenal medulla dodecapeptide in 50% TFEd3/D2O.
Note: The m/z peaks that are displayed in the spectrum and are left unlabelled
corresponds to the internal ions.
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Ta Table 3
A Amino Acid sequence-Specific Ions Observed in the CID-MS/MS Spectrum of Bovine
A Adrenal Medulla dodecapeptide in Water and 50% TFE d3/D2O Solvent Mixture
Ion type

a2
b
b3
a4
b6
b9
y2
y4
y6+2
(y8*)+2
(y10)+2

m/z in water m/z in D2O
193.2
221.1
278.2
397.2
712.3
1024.4
245.2
458.4
357.4
492.4
594.4

Hx in D2O

197.0
225.1
282.1
402.4
721.4
1039.7
250.2
467.7
365.2
500.2
602.6

4
4
4
5
9
15
3
7
12
16
17

m/z in TFE

Hx in TFE

196.1
224.0
281.0
401.6
720.4
1038.6
466.4
364.2
499.9
601.7

3
3
3
4
8
14
6
11
15
16

Table 4
Number of Hydrogens Exchanged in Various Regions of Bovine Adrenal Medulla
Dodecapeptide upon HDX in 50% TFE-d3/D2O Solvent Mixture
N-terminal
segments

Number of hydrogens
exchanged

C-terminal segments Number of hydrogens
exchanged

(% Deuterium content)

YG
4/4 (100)
YGG
4/5 (80)
YGGF
5/6 (83 )
YGGFMR
9/12 (75)
YGGFMRRV 15/19 (79)

(% Deuterium content)

EP
EPRG
EPRGVR
EPRGVRRM
EPRGVRRMFG
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3/3 (100)
7/9 (78)
12/15 (80)
16/21 (76)
17/23 (74)

b4 (5/6)

b2 (4/4)

b6 (9/12)

b9 (15/19)

NH2-Y-G-G-F-M-R-R-V-G-R-P-E-COOH
(a)

y10* (17/23)

2

1

b4 (4/6)

b2 (3/4)

y4 (7/9)

y6 (12/15)

y8 (16/21)

b6 (8/12)

3

b9 (14/19)

NH2-Y-G-G-F-M-R-R-V-G-R-P-E-COOH
(b)

y10* (16/23)

2

y8 (15/21)

y4 (6/9)
y6 (11/15)
3

3

Figure 32: Summary of the number of hydrogens exchanged on b and y fragments of
BAM 12P derived from CID-MS/MS data in (a) D2O and (b) 50% TFE-d3/D2O. The total
number of exchangeable hydrogens in different segments is represented in parenthesis
and the number of unexchanged hydrogens is shown under the bar.
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Figure 33: Circular dichroism spectra of bovine adrenal medulla dodecapeptide in
water and 50%TFE/water
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Conclusions
To accomplish the first objective in this thesis research; HDX technique was
combined with mass spectrometry to probe and compare the secondary structure of the
two opioid peptides, dynorphin A (1-8) and BAM-12P. Because these two peptides share
a common sequence from Tyr1–Arg7 (except Leu5/Met5), it is reasonable to assume that
there might be some structural similarities in these peptides. Circlular dichroism
spectroscopy has been used as an additional approach due to the availability of limited
research literature on the conformation of these peptides. The HDX experimental results
indicate that dynorphin exists as a random coil in water and attains a more compact
secondary structure in TFE, whereas BAM shows the presence of distinguishable
secondary structural elements in aqueous solvent itself, which are augmented by the
presence of TFE. From CD spectroscopy and conformation analysis of these peptides, it
is possible to reason that both dynorphin and BAM 12P adopt a ß-turn structure in TFE.
The conclusion of ß-turn conformation at N-terminal is not unreasonable because a turn
is facilitated at Gly2-Gly3 bond which is present in both the peptides [71-73].
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Chapter 4
Structural Investigation of Bombesin and Neuromedin B
Peptides Background
The purpose of this investigation is to study and compare the solution-phase
conformations of bombesin (BBS) and neuromedin B (NMB) by using
hydrogen/deuterium exchange combined with mass spectrometry. These two peptides
have a common C-terminal region G-H-X-M-NH2, except for X is Leu in BBS and Phe in
NMB. Bombesin is a 14 amino acid peptide with a sequence of q-Q-R-L-G-N-Q-W-A-VG-H-L-M-NH2. Bombesin was originally isolated from the skin of a frog. It stimulates
gastrin release from G cells by activating three different G-protein coupled receptors
known as BBR1, BBR2 and BBR3 [75]. Bombesin also activates these receptors in the
brain. It is believed that together with cholecystokinin, BBS acts as the second major
source of negative feedback signals that affects eating behavior. Neuromedin B is a
decapeptide with a sequence of G-N-L-W-A-T-G-H-F-M-NH2. Originally, NMB was
obtained from the spinal cord of pig and later it was identified in the human CNS and
gastrointestinal tract [99-101]. It is known to exert its effects by binding to Neuromedin
B receptor (NMBR), which is also a G protein-coupled receptor. NMB is also known to
regulate several factors, such as exocrine and endocrine secretions, cell growth, body
temperature, blood pressure and glucose level.
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Literature Review
A majority of previous research work has reported that BBS and NMB [76-98]
exist as random coil in water and helical conformation in membrane mimetic systems.
The NMR studies on BBS in DMSO-d6/water mixture indicate that bombesin attains a
helical structure in the C-terminal region [85]. The structural investigation of BBS in
buffer and lysophosphatidylcholine (LPC) micelles was carried out using NMR, CD and
fluorescence spectrometry. These studies revealed that the peptide exists as a random coil
in aqueous buffer, but shows secondary structure formation upon interaction with the
LPC micelles [86]. It is believed that these kinds of conformational changes might be
responsible for hormone-receptor interaction leading to various physiological effects.
Another study was carried out to investigate the structure of bombesin in organic and
aqueous solvents using NMR spectroscopy and molecular dynamics techniques [89]. This
study suggests that bombesin exists as an open conformation in pure water; whereas it
undergoes a conformational transition forming a stabilized α-helix in TFE/water mixture.
It is stated that this transformation could be the result of complete surface coating of the
bombesin molecule with H-bond promoting solvent TFE. Similarly, an NMR study of
NMB in SDS micelles and in a 50% TFE/water mixture indicates that it adopts a relaxed
helical conformation in the C-terminal region [96]. A recent study using circular
dichroism, fluorescence and molecular dynamics simulation also revealed that NMB
assumes an α-helical structure in lipid membrane [94]. An IR study of bombesin and
NMB in phospholipid bilayer also corroborated the existence of a helical structure in the
C-terminus region [90].
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Results and Discussions III
Conformational Analysis of Bombesin
Bombesin has a total of 28 exchangeable hydrogens with 13 on the amide
backbone, three on the terminals and 12 on the side chains. The most abundant peak in
water was found to be at [M+2H]2+, which upon zoom scan produced a corresponding m/z
at 810.80 (Figure 34). In pure D2O, the m/z of the doubly charged ion shifted from
810.80 to 825.42 (Figure 35), indicating an exchange of 27 out of 28 labile hydrogens
with 96.8% deuterium incorporation. Because, almost all hydrogens were exchanged, it is
concluded that the peptide exists as a random coil structure in water. The zoom scan ESI
spectra of the [M+2H]2+ region shifts to lower m/z ratios (823.91, 822.38 and 821.36) in
20%, 50% and 80% of TFE-d3 in D2O. A total of 24 (85.7%), 21(75%) and 19 (67.8%)
hydrogens were exchanged respectively, in these solvent systems indicating the
transition in conformation from predominantly random coil open structure to a more
compact structure with increase in the TFE content.
The data obtained for time-resolved experiments of bombesin in D2O and 50%
TFE-d3/D2O solvent is displayed in Figure 39. It is obvious that the HDX profiles in the
two different solvents for bombesin are quite distinct. A rapid exchange of labile
hydrogens with the external solvent is observed in pure D2O as shown by the upper curve
whereas the exchange is slow in the 50% TFE-d3/D2O solvent system (lower curve).
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Figure 34. Zoom scan spectrum of bombesin in water.

76

Figure 35. Zoom scan spectrum of bombesin in pure D2O.
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Figure 36. Zoom scan spectrum of bombesin in 20% TFE-d3/D2O.
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Figure 37. Zoom scan spectrum of bombesin in 50% TFE-d3/D2O.
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Figure 38. Zoom scan spectrum of bombesin in 80% TFE-d3/D2O.
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Figure 39. Plot of the number of hydrogens exchanged in bombesin as a function of time
in water and 50% TFE.
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MS/MS Analysis for Bombesin
For identifying the individual amino acids involved in the secondary structure
formation, the CID-MS/MS spectra were acquired for mass-selected doubly charged
precursor ions at m/z 810.80 and 825.42 (Figures 40 and 41) in water and 50% TFE-d3,
respectively. As expected the b and y-type ions were the dominant sequence-specific ions
in these spectra. The N-terminal ions b4, b5, a7, b8, b10, b12, b13 and the C-terminal ions y2,
y4, y6, y8 and y10 were chosen to calculate the number of hydrogens exchanged (Eq 1011). A summary of the list of the ions observed and the calculated number of hydrogens
exchanged in each ion is shown in Table 5.
Interpretation of MS Data for Bombesin
From the MS/MS data for BBS, it is observed that a total of seven hydrogens (b13)
remain protected in 50% TFE-d3/D2O mixture, which also agrees with the number
(21/28) obtained by calculating the difference between the m/z values of the [M + 2D]2+
ion of the deuterated (m/z = 825.42) and the [M + 2H]2+ ion of the non-deuterated BBS
(m/z = 810.30) (Figures 37 and 34) in 50% solvent mixture and water respectively. A
list of the number of labile hydrogens exchanged in the individual fragment ions upon
MS/MS analysis of BBS in 50% TFE-d3/D2O is given in Table 6. In the segment Glp1Leu4, all 10 labile hydrogens undergo exchange with 100% deuterium incorporation. It is
clear that the N-terminal of bombesin exhibits a flexible conformation. It is also observed
that only 11 out of 18 hydrogens were exchanged in the Gly5-Met14 residue with a
deuterium incorporation of 61.1%. Therefore, the seven hydrogens that remained
unexchanged belong to Gly5-Met14 portion of the peptide.
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From the detailed data analysis (similar to dynorphin) for the remaining segments listed
in the Table 6, it can be summarized (Figure 42) that out of seven hydrogens that
remained unexchanged in 50% TFE-d3/D2O solvent mixture, four belong to the Gly5Trp8 segment, one to the Ala9-Val10 region and the remaining two to the Gly11- Met14
portion. Thus, by correlating the current data with previous research work, it is possible
to conclude that the N-terminal region of bombesin remains free and the remaining
region of the peptide (Gly5-Met14) assumes helical conformation in the 50% TFE-d3/D2O
solvent mixture [85,86,89].
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b8

b10

b4
b5
y4

b12

a7

y6

y10

y8

b13

Figure 40. CID-MS/MS spectrum of bombesin in water.
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y8

y6
b5

a7

b8

b10

y4 b4
y10

b12
b13

Figure 41. CID-MS/MS spectrum of bombesin in 50% TFE-d3/D2O.
Note: The m/z peaks that are displayed in the spectrum and are left unlabelled
corresponds to the internal ions.
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Tab Table 5
AmAmino acid sequence-specific ions observed n the CID-MS/MS spectrum of
Bombesin in water and 50 % TFE-d3/D2O solvent mixture
Ion type

m/z in water

m/z in D2O Hx in D2O

b4
b5
a7
b8
b10
b12
b13
y4
y6
y8
y10

509.30
566.39
780.35
994.43
1164.51
1358.55
1471.68
456.25
626.34
940.41
1111.43

519.30
577.38
797.32
1013.44
1185.54
1381.52
1495.70
464.26
636.31
955.51
1130.39

10
11
17
19
21
23
24
6
8
13
17

m/z in TFE

519.22
576.42
794.30
1009.39
1180.60
1376.41
1489.74
463.34
634.40
951.52
1124.34

Hx in TFE
10
10
14
15
16
18
18
5
6
9
11

Table 6
Number of Hydrogens Exchanged in Various Regions of Bombesin upon HDX in
50% TFE-d3/D2O Solvent Mixture
N-terminal segments

Number of hydrogens
exchanged

(% Deuterium content)
qQRL
qQRLG
qQRLGNQ
qQRLGNQW
qQRLGNQWAV
qQRLGNQWAVGH
qQRLGNQWAVGHL

10/10 (100)
10/11 (90.9)
14/17 (82.4)
15/19 (78.9)
6/21 (762)
18/24 (75.0)
18/25 (72.0)

C-terminal
segments

Number of
hydrogens exchanged
(% Deuterium content)

GHLM
VGHLM
AVGHLM
QWAVGHLM
QWAVGHLM
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5/7 (71.4)
5/8 (62.5)
6/9 (66.7)
9/14 (64.3)
11/18 (61.1)

b8 15(19)
b4 10(10)

b5 10(11)

a7 14(17)

b13 18(25)
b10 16(21)

q-Q-R-L-G-N-Q-W-A-V-G-H-L-M-CONH2
y4 5(7)
y6 6(9)
y10 11(18)
4

1

2

Figure 42. Summary of the number of hydrogens exchanged on b and y fragments of
bombesin derived from ESI-MS/MS data in 50% TFE-d3/D2O. The total number of labile
hydrogens in each fragment is represented in parenthesis and the number of unexchanged
hydrogens in different segments is shown under the bar.
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Results and Discussion IV
Conformational Analysis of Neuromedin B
The conformation of NMB was studied in water, D2O, 20%, 50% and 80%TFE-d3
solvents in a similar way. NMB contains of a total of 18 labile hydrogens with four on the
terminals, five on the side chains and nine on the amide backbone. The zoom scan ESI
mass spectra for the [M+2H]+2 region of NMB obtained in different specified
concentrations of the deuterated media are shown in Figures 43, 44, 45, 46 and 47. It is
observed that the m/z of NMB in water (567.30) shifted to 576.80, 576.15, 574.30 and
573.66; in pure D2O, 20, 50 and 80% TFEd3/D2O solvent mixtures. The numbers of
hydrogens exchanged in these solvents are calculated to be 17 (97.7%), 16 (88.8%),
12(66.6%) and 11(61.1%), respectively. These observations infer that the increasing
concentrations of TFE resulted in the increased number of protected hydrogens.
A time-resolved plot (Figure 48) was obtained for NMB in D2O and 50%
TFEd3/D2O solvent system. The plot was similar to that of bombesin. It is observed that
in pure D2O (upper curve), the rate of exchange was faster compared to that in 50%
solvent (lower curve). Therefore, it can be inferred that the labile hydrogens in NMB
remain protected from the deuterated solvent in 50% TFE-d3; presumably due to the
presence of a more folded structure.
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Figure 43. Zoom scan spectrum of neuromedin B in Water.

89

Figure 44. Zoom scan spectrum of neuromedin B in pure D2O.
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Figure 45. Zoom scan spectrum of neuromedin B in 20% TFE-d3/D2O.

91

Figure 46. Zoom scan spectrum of neuromedin B in 50% TFE-d3/D2O.
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Figure 47. Zoom scan spectrum of neuromedin B in 80% TFE-d3/D2O.
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Figure 48. Plot of the number of hydrogens exchanged in neuromedin B as a function of
time in water and 50% TFE.
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MS/MS Analysis for Neuromedin B
The CID-MS/MS analysis of NMB was performed at m/z 567.30 in water and at
m/z 576.80 in 50% TFE-d3/D2O solvent (Figures 49 and 50) The N-terminal b3, b4, b6, b8,
b9 ions and the C-terminal y2, y5, y6 and y7 ions were abundantly seen in the MS/MS
spectra of NMB acquired in both the deuterated media. The ions observed and their
respective m/z’s are displayed in Table 7. The table also gives information about the
calculated number of hydrogens exchanged in each ion using Eq.10 and 11 listed in
chapter 3.
Interpretation of MS Data for Neuromedin B
From the Table 8, it is derived that the first three amino acid residues (G1NL3) in
the N-terminal region undergo complete exchange (6/6 Hs) with 100% deuterium
incorporation. It is observed that a total of six hydrogens are protected in 50% TFEd3/D2O solvent mixture. Interpretation of the number of hydrogens exchanged (similar to
dynorphin) in the remaining b and y-type ions (Table 8) show that the six unexchanged
hydrogens belong to the Trp4-Met10 region of the peptide. The same conclusion is also
arrived at from the observation that six H’s are protected in all the three segments; Gly1Phe9 (b9), Trp4-Met10 (y7) and, Leu1-Met10 (y8). It is therefore concluded that the Gly1Phe3 region is free to exchange. Also the percent deuterium incorporation is found to be
significantly less in Trp4-Met10 (50.0%) residue, making it further obvious that Nterminal of NMB is flexible whereas the remaining portion is folded.
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Therefore, it can be summarized that out of the six hydrogens that are protected; two
belong to Trp4- Ala5 residue, three to the Tyr6-His8 portion and the remaining one to the
Phe9-Met10 segment. (Figure 51) Based on these observations and literature review, it can
be concluded that NMB shows a helical structure in the Trp4-Met10 segment [90, 94-96].
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b9
y6

y7

b6
y5
b4

b8
b3 y2

Figure 49. CID-MS/MS spectrum of neuromedin B in water.
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y7

y5 b6

b8

y6
b4
b3 y2

b9

Figure 50. CID-MS/MS spectrum of neuromedin B in 50% TFE-d3/D2O.
Note: The m/z peaks that are displayed in the spectrum and are left unlabelled
correspond to the internal ions.
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Ta Table 7
A Amino Acid Sequence-specific Ions Observed in the CID-MS/MS Spectrum of
N Neuromedin B in Water an and 50% TFE Solvent Mixture
Ion type m/z in water m/z in D2O Hx in D2O m/z in TFE
b3
b4
b6
b8
b9
y2
y5
y6
y7

285.35
471.36
643.42
837.65
984.53
296.25
591.61
662.41
848.51

291.34
479.34
654.40
850.61
998.50
301.22
601.59
673.38
861.50

6
8
11
13
14
3
8
9
11

Hx in TFE

291.32
478.35
651.50
846.56
993.69
300.31
598.57
669.61
856.53

6
7
8
9
9
2
5
5
6

Table 8
Number of Hydrogens Exchanged in Various Regions of Neuromedin B upon
HDX in 50% TFE-d3/D2O Solvent Mixture
N-terminal
segments

Number of hydrogens
exchanged

C-terminal
segments

(% Deuterium content)
GNL
GNLW
GNLWAT
GNLWATG
GNLWATGH
GNLWATGHF

Number of hydrogens
exchanged
(% Deuterium content)

6/6 (100)
7/8 (87.5)
8/11 (72.7)
8/12 (66.7)
9/14 (64.3)
9/1 5 (60)

FM
TGHFM
ATGHFM
WATGHFM
LWATGHFM
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2/3 (66.7)
5/9 (55.6)
5/10 (50)
6/12 (50)
7/13 (53.8)

b3 6(6)

b4 7(8) b6 8(11)

b8 9(14)

b9 9(15)

NH2-G-N-L-W-A-T-G-H-F-M-CONH2
y5 5(10)

y2 2(3)

y6 5(10)
y7 6(12)
2

3

1

Figure 51. Summary of the number of hydrogens exchanged on b and y fragments of
neuromedin B derived from ESI-MS/MS data in 50% TFE-d3/D2O. The total number of
labile hydrogens in each fragment is represented in parenthesis and the number of
unexchanged hydrogens in different segments is shown under the bar.
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Conclusions
Bombesin and NMB both exhibit random conformation in water. In bombesin, the
region from Gly5 to Met14 shows formation of secondary structural elements. Similarly in
NMB, the fragment Trp4 to Met10 shows fewer exchanged hydrogens providing the
evidence of folded conformation. These conclusions are in agreement with the studies
that indicate helical conformation in the C-terminal region of these peptides [85-92, 9496]. It has also been reported that the side chain hydrogens of these residues are not
involved in hydrogen bonding and play a key role in interacting with the receptors [93].
By considering the exchange numbers obtained for Trp8 (1/2), His12 (1/2) and Leu13 (1/1)
in bombesin and for Trp4 (1/2), His8 (1/2) and Phe9 (1/1) in NMB; it is possible to say that
the side chain hydrogens of these aminoacids are not participating in the folding of
peptide and are free to interact with the receptors; this analysis corroborates well with
previous research [93].
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Chapter 5
Conformational Characterization of Substance P and Kassinin using Mass
Spectrometry
Peptides Background
The objective of this study is to investigate and compare the solution-phase
conformation of two tachykinin peptides, substance P (SP) and kassinin using
hydrogen/deuterium exchange combined with mass spectrometry. Substance P is a
peptide with 11 amino acid residues and kassinin consists of 12 amino acid residues.
Both these peptides belong to a family of neuropeptides known as tachykinins. The
sequences of these peptides are given below:
Substance P: Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2
Kassinin:

Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2

Tachykinins share a common C-terminal sequence: Phe-X-Gly-Leu-Met-NH2, but
a different N-terminal sequence (X represents either an aromatic or a branched aliphatic
amino acid). The C-terminal region of these peptides is considered to be responsible for
receptor activation, whereas the N-terminal region determines the receptor subtype
specificity [102]. Tachykinins act through specific G-protein–coupled receptors known as
neurokinin (NK) receptors which are further classified in to NK1, NK2 and NK3
subtypes. Some of the biological functions of tachykinins include regulation of pain
transmission, hypertensive action, activation of immune system, neurogenic
inflammation, stimulation of extravascular smooth muscle and vasodilation.
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Substance P is most commonly found in mammals and its biological actions are
mediated through NK1 receptors. The other tachykinin peptides of mammalian origin are
neurokinin A (NKA) and neurokinin B (NKB) which bind to NK2 and NK3 receptors,
respectively. Substance P, NKA and NKB are the earliest known members of tachykinin
class with similar properties. Kassinin is a dodecapeptide that has been first isolated from
the skin of the african frog called kassina senegalensis. Other tachykinins of nonmammalian origin are physalaemin and eledosin. Physalalemin is selective towards a
NK1 receptor but has less affinity compared to that of substance P. The affinities of
eledosin and kassinin towards mammalian receptors are much less pronounced compared
to the other tachykinins. Eledosin and kassinin are thought to preferably bind to the Etype Eledosin receptor (SP-E) which is considered to be a combination of NK2 and NK3
receptors. Due to the lack of selectivity for a particular receptor type, tachykinins exhibit
a wide range of physiological activities [103-109, 120,121].
Literature Information
Previous research work on the conformation of substance P is vast when
compared to that of kassinin [110-122]. The important results are discussed here:
according to the CD and NMR studies performed on substance P in different solvent
systems, the peptide assumes a preferential α-helical conformation in aqueous SDS
solution. In methanol, SP showed a flexible conformation in the Arg1-Lys3 segment and
an α-helical structure in the Pro4-Phe8 segment [123]. An NMR and molecular dynamics
investigation of SP in the presence of SDS micelles also reported a partial helical
conformation [124].
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Another NMR investigation on the conformation of SP indicate that the peptide shows an
extended conformation in water but assumes a set of β- turn type structures in methanol.
It is also reported in the same study that the C-terminal segment of SP may be stabilized
by a type III consecutive β-turn [125,126]. A consecutive molecular dynamics
investigation of the SP conformation in a biphasic membrane system consisting of TIP3P
water (water model generated using computational chemistry) and carbon tetrachloride
(CCl4), reported that SP consists of two type I β-turns and one extended turn over the Cterminal residues [128]. Fewer studies have been reported on the conformational aspects
of kassinin [130,131]. In a recent NMR study, kassinin is shown to exist in a mixture of
conformations in lipid membranes; β-turn and α-helix. The β-turn is present in the Nterminal portion and the α-helix in the remaining portion [131].
Results and Discussions V
Conformational Analysis of Substance P
The corresponding zoom scan spectra of the [M+2H]2+ region of Substance P
obtained in water, D2O, 20%, 50% and 80% of TFE-d3/D2O are shown in Figures 52 to
56. The total number of labile hydrogens in this peptide is calculated to be 22 with eight
amide, four terminal and 10 side chain hydrogens. The shift from m/z 674.56 in water
(Figure 52) to m/z 686.14 in pure D2O (Figure 53), shows an average exchange of 21
hydrogens out of 22 (deuterium incorporation of 95.5%). The exchange of almost all the
hydrogens can be attributed to the absence of significant secondary structure in water.
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From Figures 54 to 56, it is observed that the isotopic peak distribution shifted to m/z
ratios 684.62, 681.24 and 681.14 in 20, 50 and 80% TFE-d3/D2O solvents. A total of 18,
11 and 11 hydrogens were exchanged, respectively, in these solvent systems with the
deuterium incorporation of 81.8%, 50% and 50% respectively.
The exchange numbers obtained in these solvents reveal that SP shows
augmented folded conformation with the increasing concentrations of TFE. Timeresolved experiments for HDX of substance P in water and 50% TFE-d3/D2O solvents
were performed and the results obtained are plotted in the Figure 57. The upper curve in
the figure is the HDX profile for substance P in D2O and the lower curve is in 50% TFEd3/D2O solution. In D2O, a rapid exchange of almost all hydrogens was observed within
one min incubation time. In TFE, the exchange was slow and did not show a major
change in the exchange numbers after 10 min and remained the same even after one hour.
Thus, it can be inferred that the peptide assumes a more ordered structure in 50% TFEd3/D2O solvent.
MS/MS Analysis for Substance P
The CID-MS/MS spectra of the mass-selected doubly charged ions at m/z 674.56
and 681.14 (Figures 58 and 59) were obtained for substance P in water and 50% TFEd3/D2O solvent, respectively. The N-terminal ions b2, b3, b6, b8, b7, b8 and the C-terminal
ions y6, y8, y9 and y10 were most abundantly seen in both these solvents. The internal ions
that are seen in the both the spectra are left unlabelled. The list of the ions obtained and
the calculated number of hydrogens exchanged in each fragment ion is shown in Table 9.
From those numbers of hydrogens exchanged, the amino acids involved in secondary
structure formation can be identified.
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Interpretation of MS Data for Substance P
In previous section, it was calculated that a total of 11 out of 22 labile hydrogens
were unexchanged in SP in 50% TFE-d3/D2O solvent mixture. A summary of the number
of hydrogens exchanged in different fragments of SP is displayed in Table 10. Detailed
analysis (similar to that of dynorphin) of this information shows that among the 11
unexchanged hydrogens, four belong to the Arg1-Pro4 fragment, three to the Gln5, Gln6
residues and remaining four to the C-terminal Phe8-Met11 segment (Figure 60). It is also
observed that the same number of hydrogens remained unexchanged in both the Arg1Phe7 (9/16) and Arg1-Phe8 (9/17) portions confirming that the Phe7 residue remains free.
Using the data analysis and previous MD study of SP conformation in a biphasic
membrane system, it is possible to say that SP might contain two β-turns followed by an
extended turn in the C-terminal of the peptide. The first turn could be due to bonding
between carbonyl group of Pro2 and the amide hydrogen of Gln5. The second turn could
be due to a similar bond between Gln5 and Phe8. The third turn is a result of an extended
turn between Phe7 and Leu10/Met11 [128].
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Figure 52. Zoom scan spectrum of substance P in water.
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Figure 53. Zoom scan spectrum of substance P in pure D2O.
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Figure 54. Zoom scan spectrum of substance P in 20% TFE-d3/D2O.
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Figure 55. Zoom scan spectrum of substance P in 50% TFE-d3/D2O.
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Figure 56. Zoom scan spectrum of substance P in 80% TFE-d3/D2O.
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Figure 57. Plot of the number of hydrogens exchanged in substance P as a function of
time in water and 50% TFE.
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b2
b8
b4

y6

y8

Figure 58. CID-MS/MS Spectrum of substance P in water.
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y9
y10

b7

b8

b6
b2

b4

y6

y8

y9

y10

Figure 59. CID-MS/MS Spectrum of substance P in 50% TFE-d3/D2O.
Note: The m/z peaks that are displayed in the spectrum and are left unlabelled
corresponds to the internal ions.
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TaTable 9
Amino Acid Sequence-Specific Ions Observed in the CID-MS/MS Spectrum of
Substance P in Water an and 50% TFE-d3/D2O Solvent Mixture
Ion type

m/z in water

b2
b4
b6
b7
b8
y6
y8
y9
y10

254.36
382.52
735.73
882.82
1029.88
741.58
966.72
1094.87
1191.90

m/z in D2O
259.32
390.48
749.69
897.76
1045.78
753. 49
981.75
1112.92
1209.86

Hx in D2O
5
8
14
15
16
10
13
16
16

m/z in TFE

257.38
387.63
743.84
891.94
1039.01
748.76
974.85
1105.05
1202.04

Hx in TFE
3
5
8
9
9
5
6
8
8

Table 10
Number of Hydrogens Exchanged in Various Regions of Substance P upon HDX
in 50% TFE-d3/D2O Solvent Mixture
N-terminal
segmens

Number of hydrogens
exchanged

C-terminal
segments

(% Deuterium content)
RP
RPKP
RPKPQQ
RPKPQQF
RPKPQQFF

3/6 (50)
5/9 (55.6)
8/15 (53.3)
9/16 (56.3)
9/17 (52.9)

Number of hydrogens
exchanged

(% Deuterium content)
QFFGLM
PQQFFGLM
KPQQFFGLM
PKPQQFFGLM
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5/10 (50)
6/13 (46.2)
8/16 (50)
8/16 (50)

b7 9(16)
b4 5(9)

b2 3(6)

b6 8(15)

b8 9(17)

R-P-K-P-Q-Q-F-F-G-L-M-CONH2

y10 8(16)

4

y8 6(13)

y6 5(10)

4

3

Figure 60. Summary of the number of hydrogens exchanged on b and y fragments of
substance P derived from ESI-MS/MS data in 50% TFE-d3/D2O. The total number of
labile hydrogens in each fragment is represented in parenthesis and the number of
unexchanged hydrogens in different segments is shown under the bar.
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Results and Discussion VI
Conformational Analysis of Kassinin
HDX of kassinin was performed in water, D2O, 20%, 50% and 80%TFE-d3
/D2Osolvents. There are a total of 19 exchangeable hydrogens in kassinin with four on
the terminals, five on the side chains and ten on the amide backbone. The zoom scan ESI
mass spectra (Figures 61 to 65) of the [M+2H]+2 region for kassinin ions reveal that 18
(94.7%), 15 (78.9%), 12 (68.4%) and 10 (52.6%) hydrogens were exchanged,
respectively. The increase in the number of protected hydrogens with the higher
concentrations of TFE-d3 is attributed to the increased folding of the peptide molecule.
Time-resolved HDX data (Figure 66) was obtained for kassinin in D2O and 50%
TFE-d3 /D2O solvent. It is obvious that in 50% TFE-d3 /D2O (lower curve), the rate of
exchange was slower compared to that in pure D2O (upper curve). Therefore, it is
possible to say that the peptide shows a random structure in water and attains a compact
conformation in the 50% solvent mixture.
MS/MS Analysis for Kassinin
The CID-MS/MS analysis of kassinin performed in D2O and 50% TFE-d3
revealed that the N-terminal ions: b2, a5, b7, b8, b9, b10, b11 and the C-terminal ions: y3,
y7*, y8*, y10* and y11* were abundant in both the deuterated media (Table 11). The spectra
obtained are shown in the Figures 67 and 68.
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Interpretation of MS Data for kassinin
Scrutiny of the CID-MS/MS data for the peptide in 50% TFE-d3/D2O solvent
mixture provides information about the amino acids involved in the secondary structure
formation of kassinin. A total of seven out of 19 labile hydrogens did not undergo HDX.
Table 12 summarizes a list of fragments that are considered for secondary structural
analysis. It is observed that four out of seven, nine out of 13, nine out of 14 and 10 out of
15 hydrogens have exchanged in the N-terminal segments, Asp1-Ser5, Asp1-Phe8, Asp1Val9 and Asp1-Gly10 respectively. These numbers were compared with the exchanged
numbers obtained in the C-terminal fragments; Gly10-Met12 (3/5) Pro3-Met12 (10/15) and
Val2-Met12 (10/16). The summary of the number of hydrogens unexchanged in different
regions of the peptide is pictorially depicted in Figure 69. Thus, it can be concluded that
two out of seven protected hydrogens belong to the Asp1-Val2 segment, two to the Lys4Gln7 portion, one to the Val9 residue, and the remaining two to the C-terminal Leu11Met12 region.
From the data obtained here and previous research work [131], it is further
possible to conclude that kassinin shows a helical conformation in the Lys4-Met12
segment. The two hydrogens that remained unexchanged in the Asp1-Pro3 portion may be
due to a β-turn between the carbonyl group of Pro-3 and the amide hydrogen of Asp-1
residues.
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Figure 61. Zoom scan spectrum of kassinin in water.
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Figure 62. Zoom scan spectrum of kassinin in pure D2O.
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Figure 63. Zoom scan spectrum of kassinin in 20% TFE-d3/D2O.
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Figure 64. Zoom scan spectrum of kassinin in 50% TFE-d3/D2O.

122

Figure 65. Zoom scan spectrum of kassinin in 80% TFE-d3/D2O.
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Figure 66. Plot of the number of hydrogens exchanged in kassinin as a function of time
in water and 50% TFE.

124

b11

b7

y10*
y7*

b10
b8
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b2
y3

y11*

a5

Figure 67. CID-MS/MS Spectrum of kassinin in water.
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b9

b11
b7 y7*

y10*

y3

b10
b2

a5

b8

y11*

Figure 68. CID-MS/MS Spectrum of kassinin in 50% TFE-d3/D2O.
Note: The m/z peaks that are displayed in the spectrum and are left unlabelled
corresponds to the internal ions.
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TabTable 11
A Amino Acid Sequence-Specific Ions Observed in the CID-MS/MS spectrum of
KaKassinin in Water and 50% TFE-d3/D2O Solvent Mixture

Ion type

m/z in water

m/z in D2O

b2
a5
b7
b8
b9
b10
b11
y3
y7*
y10*
y11*

215.16
499.60
770.66
917.75
1016.88
1073.82
1186.96
319.24
791.60
1103.97
1201.04

219.20
506.58
781.62
929.70
1029.86
1087.80
1201.95
326.22
802.58
1117.98
1216.01

Hx in D2O m/z in TFE
4

Hx in TFE

217.34
503.52
778.73
926.81
1025.89
1083.95
1197.07
324.40
799.80
1114.01
1211.03

7
11
12
13
14
15
5
11
14
15

2
4
8
9
9
10
10
3
8
10
10

Table 12
Number of Hydrogens Exchanged in Various Regions of Kassinin upon HDX in
50% TFE-d3/D2O Solvent Mixture
N-terminal
segments

Number of hydrogens
exchanged

C-terminal
segments

(% Deuterium content)
DV
DVPKS
DVPKSDQ
DVPKSDQF
DVPKSDQFV
DVPKSDQFVG
DVPKSDQFVGL

2/4 (50)
4/7 (57.1)
8/12 (66.7)
9/13 (69.2)
9/14 (64.3)
10/15 (66.7)
10/16 (62.5)

Number of hydrogens
exchanged
(% Deuterium content)

GLM
DQFVGLM
PKSDQFVGLM
VPKSDQFVGLM
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3/5 (60)
8/12 (66.7)
10/15 (66.7)
10/16 (62.5)

b3 2(4)

b7 8(12)

a5 4(7)

b9 9(14)
b10 10(15)

D-V-P-K-S-D-Q-F-V-G-L-M-CONH2
y10 10(15)

2

y3 3(5)

y7 8(12)

2

1

2

Figure 69. Summary of the number of hydrogens exchanged on b and y fragments of
kassinin derived from CID-MS/MS data in 50% TFE-d3/D2O. The total number of labile
hydrogens in each fragment is represented in parenthesis and the number of unexchanged
hydrogens in different segments is shown under the bar.
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Conclusions
The data obtained from the conformational studies of Substance P in water and
different concentrations of TFE show that the peptide predominantly assumes random
coil in water. When exposed to different concentrations of deuterated solvent mixtures of
water and TFE, SP showed a decrease in the number of exchangeable hydrogens
indicating that it forms a more ordered structure with increasing concentrations of the
organic solvent. A detailed MS/MS analysis of the peptide in 50% TFE-d3 /D2O solvent
mixture gave a clear picture of the fragments contributing to the secondary structural
elements. Considering the data and the literature review, it can be concluded that SP
contains three β-turns; one is due to the bond between the carbonyl group of Pro-2 and
the amide hydrogen of Gln-5, the other two turns are due to similar bonding between
Gln-5 and Phe-8; Phe-7 and Leu-10/Met-11 residues. Kassinin also exhibited an open
conformation in water and showed a more ordered structure in 50% solvent mixture.
From the MS/MS data analysis and previous research work, it is observed that kassinin
shows a helical conformation in the Lys4-Met12 segment and a β-turn in the N-terminal
Asp1-Pro3 region. It is therefore possible to say that the receptor subtype specificity of
these peptides may be due to the differences they exhibit in their conformational
transition upon contact with the receptor [102-106].
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Chapter 6
Conclusions
This thesis research discusses the coupling of HDX principle with ESI/MS
techniques to investigate the solution conformations of six biologically active peptides
namely dynorphin A (1-8), bovine adrenal medulla dodecapeptide, bombesin,
neuromedin B, substance P and kassinin.
The HDX results show that all the peptides except BAM 12P assume open
conformation in water. The differential behavior of BAM 12P complies well with the
data obtained from time-resolved experiments of the peptide in D2O and 50%TFEd3/D2O, where it shows nearly similar conformations in both the solvent systems. The
peptides demonstrate augmented folded conformations with increasing concentrations of
TFE-d3, owing to the secondary structure promoting properties of TFE.
The HDX profiles of these peptides at the residue level expose those amide
hydrogens that are involved in the folding of the peptide. The opioid peptides dynorphin
and BAM 12P, both show β turn conformation in 50%TFE-d3/D2O. These results also
corroborate with the CD profiles of both the peptides in water and TFE. While CD profile
for BAM 12P in water did not provide information on its ordered conformation, CIDMS/MS results for the peptide in D2O reveal that BAM 12P shows reduced deuterium
incorporation in the Gly3-Arg10 region.
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The G-protein coupled receptors acting peptides bombesin and NMB, both show flexible
conformation in the N-terminal region and ordered structure in the remaining portion of
these peptides. Bombesin adapts α-helical conformation in the Gly5 to Met14 segment and
NMB shows helical structure in the Trp4 to Met10 portion.
The tachykinin peptides SP and kassinin, exhibit folded conformation along the
entire peptide sequence. SP contains three β-turns; one is due to the bond between the
carbonyl group of Pro-2 and the amide hydrogen of Gln-5, the other two turns are due to
similar bonding between Gln-5 and Phe-8; Phe-7 and Leu-10/Met-11 residues. Kassinin
adapts helical conformation in the Lys4-Met12 segment and a β-turn in the N-terminal
Asp1-Pro3 region.
Thus, the secondary structure forming elements of all the peptides have been
determined using HDX and ESI/MS. Tandem mass spectrometry demonstrates a
promising approach in identifying the amide hydrogens involved in the ordered
conformation of the target peptides.
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